Арилжаа Eisai Co., Ltd. - 4523 CFD

Арилжааны нөхцөл

• Төрөл: CFD
• Спред: 12.9
• Лонг позицын шөнийн санхүүжилтийн тохируулга: -0.01305%
• Шорт позицын нэг шөнийн санхүүжилтийн тохируулга: -0.00917%
• Шөнийн санхүүжилтийг тохируулах хугацаа: 22:00 (UTC)
• Валют: JPY
• Арилжаалсан доод хэмжээ: 1
• Маржин: 5.00%
• Хөрөнгийн бирж: Japan
• Арилжааны шимтгэл: 0%
• Баталгаат стопын шимтгэл: 1%

Гол үзүүлэлтүүд

• Өмнөх Хаах: 4487.5
• Нээх: 4483.8
• 1 жилийн өөрчлөлт: 1.56%
• Өдрийн диапазон: 4483.8 - 4565.6

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; BELVIQ for the treatment for chronic weight management; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which includes third-class OTC drugs, designated quasi-drugs, and food with nutrient function. Eisai Co., Ltd. has a collaboration agreement with Personal Genome Diagnostics Inc. to develop liquid biopsy biomarker discovery solution. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was founded in 1941 and is headquartered in Tokyo, Japan.